Significant proportion of breast cancers exhibit dysregulation of cell cycle networks, specifically the cyclin D1-CDK4/6-RB pathway [38], and antiestrogens have been shown to inhibit the phosphorylation of RB causing G1 arrest [18, 20, 39]. This evidence concerns the gene RB1 and breast carcinoma.